Human Recombinant NAP-2 (from E. coli)
Supplier: Shenandoah Biotechnology
100-210-5UG
100-210-100UG
100-210-500UG
100-210-1MG
100-210-25UG
SHBT100-210-5UGEA
72.4
EUR
SHBT100-210-5UG
SHBT100-210-100UG
SHBT100-210-500UG
SHBT100-210-1MG
SHBT100-210-25UG
Human Recombinant NAP-2 (from E. coli)
Proteins and Peptides
Neutrophil activating peptide 2 (NAP-2), also known as CXCL7, is a member of the CXC family of chemokines. NAP-2 is a carboxyl-terminal fragment produced by proteolytic cleavage of the platelet basic protein (PBP). NAP-2 is released from platelets and binds to the receptors CXCR1 and CXCR2 to chemoattract and activate neutrophils during inflammatory events.
- High quality
- Low endotoxin
- Affordable
Caution: For research use only.
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...